Citations (73)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Li-Zhi Wu, Mao-Ling Huang, Cheng-Lin Qi, Li-Jun Shen, You Zou, Rui Yang, Jian-Fei Sheng & Shi-Ming Chen. (2021) Overexpression of Notch2 enhances radiosensitivity via inhibition of the AKT/mTOR signaling pathway in nasopharyngeal carcinoma. Bioengineered 12:1, pages 3398-3409.
Read now
Read now
Meysam Yazdankhah, Peng Shang, Sayan Ghosh, Imran A. Bhutto, Nadezda Stepicheva, Rhonda Grebe, Stacey Hose, Joseph Weiss, Tianqi Luo, Subrata Mishra, S. Amer Riazuddin, Arkasubhra Ghosh, James T. Handa, Gerard A. Lutty, J. Samuel Zigler$suffix/text()$suffix/text() & Debasish Sinha. (2020) Modulating EGFR-MTORC1-autophagy as a potential therapy for persistent fetal vasculature (PFV) disease. Autophagy 16:6, pages 1130-1142.
Read now
Read now
Anne-Kathrin Hess, Korinna Jöhrens, Andre Zakarneh, Panagiotis Balermpas, Jens Von Der Grün, Claus Rödel, Wilko Weichert, Michael Hummel, Ulrich Keilholz, Volker Budach & Ingeborg Tinhofer. (2019) Characterization of the tumor immune micromilieu and its interference with outcome after concurrent chemoradiation in patients with oropharyngeal carcinomas. OncoImmunology 8:8.
Read now
Read now
Articles from other publishers (70)
Jin SongXiaolong XuShasha HeNing WangYunjing BaiZhaoxia ChenBo LiShengsheng Zhang. (2023) Myristicin Suppresses Gastric Cancer Growth via Targeting the EGFR/
ERK Signaling Pathway. Current Molecular Pharmacology 16:7.
Crossref
Crossref
Natalia Ricco & Stephen J. Kron. (2023) Statins in Cancer Prevention and Therapy. Cancers 15:15, pages 3948.
Crossref
Crossref
João P. N. Silva, Bárbara Pinto, Luís Monteiro, Patrícia M. A. Silva & Hassan Bousbaa. (2023) Combination Therapy as a Promising Way to Fight Oral Cancer. Pharmaceutics 15:6, pages 1653.
Crossref
Crossref
Myung Woul Han. (2023) The Mechanisms and Overcoming Strategies of the Radioresistance in Head and Neck Cancer. Korean Journal of Otorhinolaryngology-Head and Neck Surgery 66:5, pages 295-301.
Crossref
Crossref
Yunhe Lin, Siwei Li, Chuzi Mo, Hongyu Liu, Jiaming Bi, Shuaimei Xu, Bo Jia, Chengxia Liu & Zhongjun Liu. (2023) Oral microbial changes and oral disease management before and after the treatment of hematological malignancies: a narrative review. Clinical Oral Investigations 27:8, pages 4083-4106.
Crossref
Crossref
Sebastian Burkart, Christopher Weusthof, Karam Khorani, Sonja Steen, Fabian Stögbauer, Kristian Unger, Julia Hess, Horst Zitzelsberger, Claus Belka, Ina Kurth & Jochen Hess. (2023) A Novel Subgroup of UCHL1-Related Cancers Is Associated with Genomic Instability and Sensitivity to DNA-Damaging Treatment. Cancers 15:6, pages 1655.
Crossref
Crossref
Yong-jian Hu, Gui-yuan Song, Fan Zhang, Nan Zhang, Fei Wang, Jing-long Wang, Xia Wang, Tao-yang Wang, Yu-feng Li, Yi-di Yan, Wen-tao Dou, Chen-yi Cheng & Ping Xu. (2023) Activation of long-non-coding RNA NEAT1 sponging microRNA-147 inhibits radiation damage by targeting PDPK1 in troxerutin radioprotection. iScience 26:2, pages 105932.
Crossref
Crossref
Wenjing Liu, Min Zheng, Rou Zhang, Qiuyun Jiang, Guangshi Du, Yingying Wu, Chuanyu Yang, Fubing Li, Wei Li, Luzhen Wang, Jiao Wu, Lei Shi, Wenhui Li, Kai Zhang, Zhongmei Zhou, Rong Liu, Yingzheng Gao, Xinwei Huang, Songqing Fan, Xu Zhi, Dewei Jiang & Ceshi Chen. (2022) RNF126‐Mediated MRE11 Ubiquitination Activates the DNA Damage Response and Confers Resistance of Triple‐Negative Breast Cancer to Radiotherapy. Advanced Science 10:5.
Crossref
Crossref
Ryan T. Morse, Rohit G. Ganju, Rishi Neeranjun, Gregory N. Gan, Ying Cao, Prakash Neupane, Kiran Kakarala, Yelizaveta Shnayder & Christopher E. Lominska. (2023) Treatment Tolerance of Cetuximab versus Alternative Chemotherapy Agents in Non-Cisplatin Candidates with Head and Neck Cancer Receiving Concurrent Chemoradiotherapy. Chemotherapy 68:1, pages 35-43.
Crossref
Crossref
Kui Tian, Zhenggui Tao, Yu Chen, Jinghu Du, Manyu Chen, Donghua Wang & Zijia Li. (2023) KCNE4 expression is correlated with the pathological characteristics of colorectal cancer patients and associated with the radioresistance of cancer cells. Pathology - Research and Practice 241, pages 154234.
Crossref
Crossref
Xiankuan Li, Ying Zhao, Sihan Gong, Tianbao Song, Jiaming Ge, Jiarong Li, Jian Zhang, Kun Fu, Yanchao Zheng & Lin Ma. (2023) Schisandrin B ameliorates acute liver injury by regulating EGFR-mediated activation of autophagy. Bioorganic Chemistry 130, pages 106272.
Crossref
Crossref
Yu-Chieh Su, Wei-Chang Lee, Chih-Chun Wang, Shyh-An Yeh, Wen-Hui Chen & Po-Jen Chen. (2022) Targeting PI3K/AKT/mTOR Signaling Pathway as a Radiosensitization in Head and Neck Squamous Cell Carcinomas. International Journal of Molecular Sciences 23:24, pages 15749.
Crossref
Crossref
Yanhui Wan, Youhui Qian, Youyu Wang, Fuyuan Fang & Guodong Wu. (2022) Prognostic value of Beclin 1, EGFR and ALK in non-squamous non-small cell lung cancer. Discover Oncology 13:1.
Crossref
Crossref
Chengzhi Gui, Mingyu Ji, Yiying Song, Jing Wang & Yunying Zhou. (2022) Functions and modulation of PKM2 activity by human papillomavirus E7 oncoprotein (Review). Oncology Letters 25:1.
Crossref
Crossref
Mohammad Azam Ansari, Muthu Thiruvengadam, Baskar Venkidasamy, Mohammad N. Alomary, Ahmad Salawi, Ill-Min Chung, Mohammad Ali Shariati & Maksim Rebezov. (2022) Exosome-based nanomedicine for cancer treatment by targeting inflammatory pathways: Current status and future perspectives. Seminars in Cancer Biology 86, pages 678-696.
Crossref
Crossref
Zhongqi Shen, Meng Yu & Shaozhi Zhang. (2022) Network Pharmacology and Molecular Docking Analyses Unveil the Mechanisms of Yiguanjian Decoction against Parkinson’s Disease from Inner/Outer Brain Perspective. BioMed Research International 2022, pages 1-25.
Crossref
Crossref
Xue Li, Fang Wang, Huijun Jia, Zhen Lian, Kai Ren, Zhiyong Yuan, Ping Wang & Lujun Zhao. (2022)
Efficacy and safety of
EGFR
inhibitors and radiotherapy in locally advanced non-small-cell lung cancer: a meta-analysis
. Future Oncology 18:27, pages 3055-3065.
Crossref
Crossref
Jian-Song Liu, Li-Ping Luo, Geng Xu, Xiao-Jia Xu, Chao Xu, E Ou, Han-Yuan Zhang, Zheng-Qiang Yuan & Yu Zhao. (2022) Synthesis and Biological Evaluation of Steviol Derivatives with Improved Cytotoxic Activity and Selectivity. Journal of Natural Products 85:8, pages 1945-1958.
Crossref
Crossref
Zejia Yang, Jipei Liao, Lisa Schumaker, Brandon Carter-Cooper, Rena G. Lapidus, Xiaoxuan Fan, Daria A. Gaykalova, Ranee Mehra, Kevin J. Cullen & Hancai Dan. (2022) Simultaneously targeting ErbB family kinases and PI3K in HPV-positive head and neck squamous cell carcinoma. Oral Oncology 131, pages 105939.
Crossref
Crossref
Yan Fang & Dajun Fang. (2022) Comprehensive analysis of placental gene-expression profiles and identification of EGFR-mediated autophagy and ferroptosis suppression in intrahepatic cholestasis of pregnancy. Gene 834, pages 146594.
Crossref
Crossref
Guihong Liu, Song Yang, Yang Liu, Yumei Xu, Hui Qiu, Jian Sun, Jun Song & Linsen Shi. (2022) The adenosine-A2a receptor regulates the radioresistance of gastric cancer via PI3K-AKT-mTOR pathway. International Journal of Clinical Oncology 27:5, pages 911-920.
Crossref
Crossref
Changxian Shen, Duan-Liang Shyu, Min Xu, Linlin Yang, Amy Webb, Wenrui Duan & Terence M. Williams. (2022) Deregulation of AKT–mTOR Signaling Contributes to Chemoradiation Resistance in Lung Squamous Cell Carcinoma. Molecular Cancer Research 20:3, pages 425-433.
Crossref
Crossref
Camil Ciprian Mireștean, Roxana Irina Iancu & Dragoș Petru Teodor Iancu. (2022) Micro-RNAs, the Cornerstones of the Future of Radiobiology in Head and Neck Cancers?. Current Oncology 29:2, pages 816-833.
Crossref
Crossref
Runze Xu, Ran Xu, Yuanxiang Wang, Weixing Wang, Lingling Jiang & Shishun Gong. (2022) G-Protein-Coupled Receptor Kinase-Interacting Protein 1 (GIT1) Promotes Head and Neck Squamous Cell Carcinoma Metastases via Activating the PI3K/AKT/mTOR Signal Pathway. Computational and Mathematical Methods in Medicine 2022, pages 1-9.
Crossref
Crossref
Sabeeha Ali, Manzar Alam & Md. Imtaiyaz Hassan. 2022. Protein Kinase Inhibitors. Protein Kinase Inhibitors
1
22
.
Forough Alemi, Aydin Raei sadigh, Faezeh Malakoti, Yusuf Elhaei, Seyed Hamed Ghaffari, Masomeh Maleki, Zatollah Asemi, Bahman Yousefi, Niloufar Targhazeh & Maryam Majidinia. (2021) Molecular mechanisms involved in DNA repair in human cancers: An overview of PI3k/Akt signaling and PIKKs crosstalk. Journal of Cellular Physiology 237:1, pages 313-328.
Crossref
Crossref
Joanna Kałafut, Arkadiusz Czerwonka, Alinda Anameriç, Alicja Przybyszewska-Podstawka, Julia O. Misiorek, Adolfo Rivero-Müller & Matthias Nees. (2021) Shooting at Moving and Hidden Targets—Tumour Cell Plasticity and the Notch Signalling Pathway in Head and Neck Squamous Cell Carcinomas. Cancers 13:24, pages 6219.
Crossref
Crossref
Lingling Gao, Xin Nie, Rui Gou, Yuexin Hu, Hui Dong, Xiao Li & Bei Lin. (2021) Exosomal ANXA2 derived from ovarian cancer cells regulates epithelial‐mesenchymal plasticity of human peritoneal mesothelial cells. Journal of Cellular and Molecular Medicine 25:23, pages 10916-10929.
Crossref
Crossref
Aimen Sultan, Namood-E Sahar, Syeda Kiran Riaz, Javeria Qadir, Shahzad Hussain Waqar, Farhan Haq, Tanwir Khaliq & Muhammad Faraz Arshad Malik. (2021) Metadherin (MTDH) overexpression significantly correlates with advanced tumor grade and stages among colorectal cancer patients. Molecular Biology Reports.
Crossref
Crossref
Tianhong Su, Manling Huang, Junbin Liao, Shuibin Lin, Peng Yu, Jianhua Yang, Yuhong Cai, Shenghua Zhu, Lixia Xu, Zhenwei Peng, Sui Peng, Shuling Chen & Ming Kuang. (2021) Insufficient Radiofrequency Ablation Promotes Hepatocellular Carcinoma Metastasis Through N6‐Methyladenosine mRNA Methylation‐Dependent Mechanism. Hepatology 74:3, pages 1339-1356.
Crossref
Crossref
Madhuri Grover, Tapan Behl, Monika Sachdeva, Simona Bungao, Lotfi Aleya & Dhruv Setia. (2021) Focus on Multi-targeted Role of Curcumin: a Boon in Therapeutic Paradigm. Environmental Science and Pollution Research 28:15, pages 18893-18907.
Crossref
Crossref
Nader Akbari Dilmaghani, Ava Safaroghli‐Azar, Atieh Pourbagheri‐Sigaroodi & Davood Bashash. (2021) The PI3K/Akt/mTORC signaling axis in head and neck squamous cell carcinoma: Possibilities for therapeutic interventions either as single agents or in combination with conventional therapies. IUBMB Life 73:4, pages 618-642.
Crossref
Crossref
Kelvin Anderson, Nathan Ryan, Anastasia Alkhimovitch, Arham Siddiqui & Steve Oghumu. (2021) Inhibition of PI3K Isoform p110γ Increases Both Anti-Tumor and Immunosuppressive Responses to Aggressive Murine Head and Neck Squamous Cell Carcinoma with Low Immunogenicity. Cancers 13:5, pages 953.
Crossref
Crossref
Mandana T. Manzari, Yosi Shamay, Hiroto Kiguchi, Neal Rosen, Maurizio Scaltriti & Daniel A. Heller. (2021) Targeted drug delivery strategies for precision medicines. Nature Reviews Materials 6:4, pages 351-370.
Crossref
Crossref
Elham Nafea Alsahafi, Selvam Thavaraj, Nazanin Sarvestani, Ofra Novoplansky, Moshe Elkabets, Bushra Ayaz, Mahvash Tavassoli & Main Figures Legends. (2021) EGFR overexpression increases radiotherapy response in HPV-positive head and neck cancer through inhibition of DNA damage repair and HPV E6 downregulation. Cancer Letters 498, pages 80-97.
Crossref
Crossref
Fu-Cheng Chuang, Chih-Chun Wang, Jian-Han Chen, Tzer-Zen Hwang, Shyh-An Yeh & Yu-Chieh Su. (2021) PI3k inhibitors (BKM120 and BYL719) as radiosensitizers for head and neck squamous cell carcinoma during radiotherapy. PLOS ONE 16:1, pages e0245715.
Crossref
Crossref
George D. Wilson, Thomas G. Wilson, Alaa Hanna, Mohamad Dabjan, Katie Buelow, John Torma, Brian Marples & Sandra Galoforo. (2021) Dacomitinib and gedatolisib in combination with fractionated radiation in head and neck cancer. Clinical and Translational Radiation Oncology 26, pages 15-23.
Crossref
Crossref
Shanwei Shi, Huigen Luo, Lihong Wang, Hua Li, Yujie Liang, Juan Xia, Zhi Wang, Bin Cheng, Linfeng Huang, Guiqing Liao & Baoshan Xu. (2021) Combined inhibition of RNA polymerase I and mTORC1/2 synergize to combat oral squamous cell carcinoma. Biomedicine & Pharmacotherapy 133, pages 110906.
Crossref
Crossref
Mary Glorieux, Rüveyda Dok & Sandra Nuyts. (2020) The influence of PI3K inhibition on the radiotherapy response of head and neck cancer cells. Scientific Reports 10:1.
Crossref
Crossref
Linah A. Shahoumi, Hesam Khodadadi, Husam Bensreti, Babak Baban & W. Andrew Yeudall. (2020) EPS8 phosphorylation by Src modulates its oncogenic functions. British Journal of Cancer 123:7, pages 1078-1088.
Crossref
Crossref
Katharina Hintelmann, Malte Kriegs, Kai Rothkamm & Thorsten Rieckmann. (2020) Improving the Efficacy of Tumor Radiosensitization Through Combined Molecular Targeting. Frontiers in Oncology 10.
Crossref
Crossref
Xiaofei Li, Ruifang Tian, Lan Liu, Lihui Wang, Dong He, Ke Cao, John K. Ma & Chenghui Huang. (2020) Andrographolide enhanced radiosensitivity by downregulating glycolysis via the inhibition of the PI3K-Akt-mTOR signaling pathway in HCT116 colorectal cancer cells. Journal of International Medical Research 48:8, pages 030006052094616.
Crossref
Crossref
Shuang Wu, Tiantian Yang, Kai Cen, Yihuai Zou, Xiaowei Shi, Dongrui Zhou, Yonghong Gao, Limin Chai, Yizhou Zhao, Yikun Sun & Lingqun Zhu. (2020)
In Vitro Evaluation of the Neuroprotective Effect of
Panax notoginseng
Saponins by Activating the EGFR/PI3K/AKT Pathway
. Evidence-Based Complementary and Alternative Medicine 2020, pages 1-11.
Crossref
Crossref
Chao Rong, Marie F. Muller, Fang Xiang, Alexandra Jensen, Wilko Weichert, Gerald Major, Peter K. Plinkert, Jochen Hess & Annette Affolter. (2020) Adaptive ERK signalling activation in response to therapy and in silico prognostic evaluation of EGFR-MAPK in HNSCC. British Journal of Cancer 123:2, pages 288-297.
Crossref
Crossref
Lingyuan Huang, Chanjuan Zhao, Kai Sun, Dandan Yang, Linxia Yan, Dan Luo, Jinli He, Xuemei Hu, Rong Wang, Xiaofei Shen, Ning Xiao & Zhendong Zhong. (2020) Downregulation of CLDN6 inhibits cell proliferation, migration, and invasion via regulating EGFR/AKT/mTOR signalling pathway in hepatocellular carcinoma. Cell Biochemistry and Function 38:5, pages 541-548.
Crossref
Crossref
Qiuning Zhang, Yarong Kong, Zhen Yang, Yang Liu, Ruifeng Liu, Yichao Geng, Hongtao Luo, Hong Zhang, Hongyan Li, Shuangwu Feng & Xiaohu Wang. (2020) Preliminary study on radiosensitivity to carbon ions in human breast cancer. Journal of Radiation Research 61:3, pages 399-409.
Crossref
Crossref
Oluwaseun Adebayo Bamodu, Hang-Lung Chang, Jiann-Ruey Ong, Wei-Hwa Lee, Chi-Tai Yeh & Jo-Ting Tsai. (2020) Elevated PDK1 Expression Drives PI3K/AKT/MTOR Signaling Promotes Radiation-Resistant and Dedifferentiated Phenotype of Hepatocellular Carcinoma. Cells 9:3, pages 746.
Crossref
Crossref
Katrien Konings, Charlot Vandevoorde, Bjorn Baselet, Sarah Baatout & Marjan Moreels. (2020) Combination Therapy With Charged Particles and Molecular Targeting: A Promising Avenue to Overcome Radioresistance. Frontiers in Oncology 10.
Crossref
Crossref
Li Tian, Lucas Wang, Yang Qiao, Linfeng Lu, Patrick Lee, Ashley Chang, Saisree Ravi, Thomas A. Rogers & Marites P. Melancon. (2019) Antitumor Efficacy of Liposome-Encapsulated NVP-BEZ235 Combined with Irreversible Electroporation for Head and Neck Cancer. Molecules 24:19, pages 3560.
Crossref
Crossref
K. Devaraja. (2019) Current Prospects of Molecular Therapeutics in Head and Neck Squamous Cell Carcinoma. Pharmaceutical Medicine 33:4, pages 269-289.
Crossref
Crossref
Chao Rong, Marie Muller, Christa Flechtenmacher, Dana Holzinger, Gerhard Dyckhoff, Olcay Cem Bulut, Dominik Horn, Peter Plinkert, Jochen Hess & Annette Affolter. (2019) Differential Activation of ERK Signaling in HPV-Related Oropharyngeal Squamous Cell Carcinoma. Cancers 11:4, pages 584.
Crossref
Crossref
Julius Moratin, Stefan Hartmann, Roman C. Brands, Dominik Horn, Andreas Fuchs, Grit Mutzbauer, Axel Seher, Claus Scholz, Urs D.A. Müller-Richter & Christian Linz. (2019) MicroRNA expression correlates with disease recurrence and overall survival in oral squamous cell carcinoma. Journal of Cranio-Maxillofacial Surgery 47:3, pages 523-529.
Crossref
Crossref
Zhenwen Lin, Sheng Li, Peng Guo, Liyang Wang, Lisheng Zheng, Zixing Yan, Xi Chen, Zhuqin Cheng, Haiyi Yan, Cui Zheng & Congkuai Zhao. (2019) Columbamine suppresses hepatocellular carcinoma cells through down-regulation of PI3K/AKT, p38 and ERK1/2 MAPK signaling pathways. Life Sciences 218, pages 197-204.
Crossref
Crossref
Shuang Han, Ying Chen, Yanlin Gao, Bei Sun & Yichun Kong. (2019) MicroRNA-218–5p inhibit the migration and proliferation of pterygium epithelial cells by targeting EGFR via PI3K/Akt/mTOR signaling pathway. Experimental Eye Research 178, pages 37-45.
Crossref
Crossref
Dong Jin Lee, Young-Gyu Eun, Young Soo Rho, Eui Hyun Kim, Sun Young Yim, Sang Hee Kang, Bo Hwa Sohn, Gee Hwan Kwon & Ju-Seog Lee. (2018) Three distinct genomic subtypes of head and neck squamous cell carcinoma associated with clinical outcomes. Oral Oncology 85, pages 44-51.
Crossref
Crossref
Chin‑Fu ChenChi‑Cheng LuJo‑Hua ChiangHong‑Yi ChiuJai‑Sing YangChao‑Ying LeeTzong‑Der WayHao‑Jen Huang. (2018) Synergistic inhibitory effects of cetuximab and curcumin on human cisplatin‑resistant oral cancer CAR cells through intrinsic apoptotic process. Oncology Letters.
Crossref
Crossref
Kevin Blas, Thomas G. Wilson, Nathan Tonlaar, Sandra Galoforo, Alaa Hana, Brian Marples & George D. Wilson. (2018) Dual blockade of PI3K and MEK in combination with radiation in head and neck cancer. Clinical and Translational Radiation Oncology 11, pages 1-10.
Crossref
Crossref
Daniele Xavier Assad, Gabriel Alvares Borges, Samuel Ramalho Avelino & Eliete Neves Silva Guerra. (2018) Additive cytotoxic effects of radiation and mTOR inhibitors in a cervical cancer cell line. Pathology - Research and Practice 214:2, pages 259-262.
Crossref
Crossref
Darkle Modesto Ferreira, Tercia J. Neves, Luiz Guilherme C. A. Lima, Fabio A. Alves & Maria D. Begnami. (2017) Prognostic implications of the phosphatidylinositol 3-kinase/Akt signaling pathway in oral squamous cell carcinoma: overexpression of p-mTOR indicates an adverse prognosis. Applied Cancer Research 37:1.
Crossref
Crossref
Chih-Chia Yu, Shih-Kai Hung, Hon-Yi Lin, Wen-Yen Chiou, Moon-Sing Lee, Hui-Fen Liao, Hsien-Bin Huang, Hsu-Chueh Ho & Yu-Chieh Su. (2017)
Targeting the PI3K/AKT/mTOR signaling pathway as an effectively radiosensitizing strategy for treating human oral squamous cell carcinoma
in vitro
and
in vivo
. Oncotarget 8:40, pages 68641-68653.
Crossref
Crossref
Aviram Mizrachi, Yosi Shamay, Janki Shah, Samuel Brook, Joanne Soong, Vinagolu K. Rajasekhar, John L. Humm, John H. Healey, Simon N. Powell, José Baselga, Daniel A. Heller, Adriana Haimovitz-Friedman & Maurizio Scaltriti. (2017) Tumour-specific PI3K inhibition via nanoparticle-targeted delivery in head and neck squamous cell carcinoma. Nature Communications 8:1.
Crossref
Crossref
Xuedong Wang, Jianping Zeng, Liang Wang, Xinjing Zhang, Zhiqian Liu, Hongyi Zhang & Jiahong Dong. (2017) Overexpression of microRNA-133b is associated with the increased survival of patients with hepatocellular carcinoma after curative hepatectomy: Involvement of the EGFR/PI3K/Akt/mTOR signaling pathway. Oncology Reports 38:1, pages 141-150.
Crossref
Crossref
Alexandre Bozec, Nathalie Ebran, Nina Radosevic-Robin, Emmanuel Chamorey, Hedi Ben Yahia, Serge Marcie, Mathieu Gautier, Frédérique Penault-Llorca & Gérard Milano. (2017) Combination of phosphotidylinositol-3-kinase targeting with cetuximab and irradiation: A preclinical study on an orthotopic xenograft model of head and neck cancer. Head & Neck 39:1, pages 151-159.
Crossref
Crossref
Amaury Daste, Erwan de Mones, Charles Dupin, Louis François, Alain Ravaud & Laurence Digue. (2016) m-TOR inhibitor as potential radiosensitizer for head and neck squamous cell carcinoma: A case report of an organ transplant patient and review of the literature. Oral Oncology 62, pages e1-e2.
Crossref
Crossref
John Zeng-Hong Li, Wei Gao, Wen-Bin Lei, Jing Zhao, Jimmy Yu-Wai Chan, William Ignace Wei, Wei-Kuen Ho & Thian-Sze Wong. (2016) MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma. Oncotarget 7:36, pages 58218-58233.
Crossref
Crossref
Dan Dan Zhu, Jun Zhang, Wen Deng, Yim Ling Yip, Hong Lok Lung, Chi Man Tsang, Wai Tak Law, Jie Yang, Victoria Ming Yi Lau, Wai Ho Shuen, Maria Li Lung, Annie Lai Man Cheung & Sai Wah Tsao. (2016) Significance of NF-κB activation in immortalization of nasopharyngeal epithelial cells. International Journal of Cancer 138:5, pages 1175-1185.
Crossref
Crossref
Hongxia LiLi JuanLeiming XiaYi WangYangyi BaoGuoping Sun. (2016) Thioridazine Sensitizes Esophageal Carcinoma Cell Lines to Radiotherapy-Induced Apoptosis In Vitro and In Vivo. Medical Science Monitor 22, pages 2624-2634.
Crossref
Crossref
Xiu-guo Han, Lin Du, Han Qiao, Bing Tu, Yu-gang Wang, An Qin, Ke-rong Dai, Qi-ming Fan & Ting-ting Tang. (2015) CXCR1 knockdown improves the sensitivity of osteosarcoma to cisplatin. Cancer Letters 369:2, pages 405-415.
Crossref
Crossref
Ao Guo, Dongming He, Hong-Bo Xu, Chang-An Geng & Jian Zhao. (2015) Promotion of regulatory T cell induction by immunomodulatory herbal medicine licorice and its two constituents. Scientific Reports 5:1.
Crossref
Crossref
Francesco Perri, Giuseppina Della Vittoria Scarpati & Mario Giuliano. 2015. International Manual of Oncology Practice. International Manual of Oncology Practice
605
627
.